Literature DB >> 30936148

Identification of Insulin-Responsive Transcription Factors That Regulate Glucose Production by Hepatocytes.

Liheng Wang1,2, Qiongming Liu3, Takumi Kitamoto1,2, Junjie Hou4, Jun Qin3, Domenico Accili5,2.   

Abstract

Hepatocyte glucose production is a complex process that integrates cell-autonomous mechanisms with cellular signaling, enzyme activity modulation, and gene transcription. Transcriptional mechanisms controlling glucose production are redundant and involve nuclear hormone receptors and unliganded transcription factors (TFs). Our knowledge of this circuitry is incomplete. Here we used DNA affinity purification followed by mass spectrometry to probe the network of hormone-regulated TFs by using phosphoenolpyruvate carboxykinase (Pck1) and glucose-6-phosphatase (G6pc) in liver and primary hepatocytes as model systems. The repertoire of insulin-regulated TFs is unexpectedly broad and diverse. Whereas in liver the two test promoters are regulated by largely overlapping sets of TFs, in primary hepatocytes Pck1 and G6pc regulation diverges. Insulin treatment preferentially results in increased occupancy by the two promoters, consistent with a model in which the hormone's primary role is to recruit corepressors rather than to clear activators. Nine insulin-responsive TFs are present in both models, but only FoxK1, FoxA2, ZFP91, and ZHX3 require an intact Pck1p insulin response sequence for binding. Knockdown of FoxK1 in primary hepatocytes decreased both glucose production and insulin's ability to suppress it. The findings expand the repertoire of insulin-dependent TFs and identify FoxK1 as a contributor to insulin signaling.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30936148      PMCID: PMC6610019          DOI: 10.2337/db18-1236

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.337


  45 in total

1.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

2.  Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2.

Authors:  Renaud Dentin; Yi Liu; Seung-Hoi Koo; Susan Hedrick; Thomas Vargas; Jose Heredia; John Yates; Marc Montminy
Journal:  Nature       Date:  2007-09-05       Impact factor: 49.962

3.  Corrigendum: Global quantification of mammalian gene expression control.

Authors:  Björn Schwanhäusser; Dorothea Busse; Na Li; Gunnar Dittmar; Johannes Schuchhardt; Jana Wolf; Wei Chen; Matthias Selbach
Journal:  Nature       Date:  2013-02-13       Impact factor: 49.962

4.  Sin3 interacts with Foxk1 and regulates myogenic progenitors.

Authors:  Xiaozhong Shi; Daniel J Garry
Journal:  Mol Cell Biochem       Date:  2012-04-04       Impact factor: 3.396

5.  Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes.

Authors:  Valgerdur Steinthorsdottir; Gudmar Thorleifsson; Patrick Sulem; Hannes Helgason; Niels Grarup; Asgeir Sigurdsson; Hafdis T Helgadottir; Hrefna Johannsdottir; Olafur T Magnusson; Sigurjon A Gudjonsson; Johanne M Justesen; Marie N Harder; Marit E Jørgensen; Cramer Christensen; Ivan Brandslund; Annelli Sandbæk; Torsten Lauritzen; Henrik Vestergaard; Allan Linneberg; Torben Jørgensen; Torben Hansen; Maryam S Daneshpour; Mohammad-Sadegh Fallah; Astradur B Hreidarsson; Gunnar Sigurdsson; Fereidoun Azizi; Rafn Benediktsson; Gisli Masson; Agnar Helgason; Augustine Kong; Daniel F Gudbjartsson; Oluf Pedersen; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2014-01-26       Impact factor: 38.330

Review 6.  Hormonal regulation of hepatic glucose production in health and disease.

Authors:  Hua V Lin; Domenico Accili
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

7.  Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera.

Authors:  H Htun; J Barsony; I Renyi; D L Gould; G L Hager
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

8.  In-depth proteomic characterization of endogenous nuclear receptors in mouse liver.

Authors:  Qiongming Liu; Chen Ding; Wanlin Liu; Lei Song; Mingwei Liu; Liang Qi; Tianyi Fu; Anna Malovannaya; Yi Wang; Jun Qin; Bei Zhen
Journal:  Mol Cell Proteomics       Date:  2012-11-29       Impact factor: 5.911

9.  Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs.

Authors:  Christopher John Bowman; Donald E Ayer; Brian David Dynlacht
Journal:  Nat Cell Biol       Date:  2014-11-17       Impact factor: 28.824

Review 10.  Ligands of Therapeutic Utility for the Liver X Receptors.

Authors:  Rajesh Komati; Dominick Spadoni; Shilong Zheng; Jayalakshmi Sridhar; Kevin E Riley; Guangdi Wang
Journal:  Molecules       Date:  2017-01-05       Impact factor: 4.411

View more
  4 in total

1.  Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.

Authors:  Wenchao Wu; Geoffrey M Nelson; Raphael Koch; Katherine A Donovan; Radosław P Nowak; Tayla B Heavican-Foral; Ajit J Nirmal; Huiyun Liu; Lei Yang; Jessica Duffy; Foster Powers; Kristen E Stevenson; Marcus Kenneth Jones; Samuel Y Ng; Gongwei Wu; Salvia Jain; Ran Xu; Sam Amaka; Christopher Trevisani; Nicholas L Donaldson; Patrick R Hagner; Laurence de Leval; Philippe Gaulard; Javeed Iqbal; Anjan Thakurta; Eric S Fischer; Karen Adelman; David M Weinstock
Journal:  Blood       Date:  2022-03-31       Impact factor: 25.476

2.  TOX4, an insulin receptor-independent regulator of hepatic glucose production, is activated in diabetic liver.

Authors:  Liheng Wang; Junjie Yu; Qiuzhong Zhou; Xiaobo Wang; Maria Mukhanova; Wen Du; Lei Sun; Utpal B Pajvani; Domenico Accili
Journal:  Cell Metab       Date:  2021-12-15       Impact factor: 31.373

3.  Dendrocalamus latiflorus and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production via AKT activation.

Authors:  Kun Luo; Wenting Huang; Liansheng Qiao; Xiaoling Zhang; Di Yan; Zhiyu Ning; Chengmei Ma; Honglei Dang; Dong Wang; Hongyan Guo; Lan Xie; Jing Cheng
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 14.903

4.  ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.

Authors:  Minhua Deng; Wensu Wei; Jinling Duan; Rixin Chen; Ning Wang; Leye He; Yulu Peng; Xiaodan Ma; Zeshen Wu; Jianye Liu; Zhiyong Li; Zhiling Zhang; Lijuan Jiang; Fangjian Zhou; Dan Xie
Journal:  Cancer Sci       Date:  2021-03-09       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.